Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C Virus Infection

Explore clinical trials studying Hepatitis C Virus Infection. Study availability and eligibility vary by location and protocol.

79 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C Virus Infection trial results

Completed

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and Cirrhosis

NCT02781558

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Hospital Universitario Marques de Valdecilla Santander, Cantabria, Spain
  • Hospital Universitario de A Coruña A Coruña, Spain
  • Hospital Universitario Fundacion Alcorcon Alcorcón, Spain
  • Hospital General Universitario De Alicante Alicante, Spain
View all 28 locations
View Trial Details
Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting

NCT02350569

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
Locations
  • San Francisco, California, United States
  • Chicago, Illinois, United States
  • New Orleans, Louisiana, United States
  • Detroit, Michigan, United States
View Trial Details
Completed

Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study

NCT02300103

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • San Diego, California, United States
  • San Marcos, California, United States
  • Aurora, Colorado, United States
  • Gainesville, Florida, United States
View all 30 locations
View Trial Details
Completed

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

NCT02201953

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
Locations
  • Los Angeles, California, United States
  • Los Angeles, California, United States
  • Sacramento, California, United States
  • San Diego, California, United States
View all 76 locations
View Trial Details

Related conditions